Decisions of Annual General Meeting of AS Harju Elekter Group The Annual General Meeting of Shareholders of AS Harju Elekter Group was held on 26 April 2024 starting at 14 p.m., at the Swissotel Tallinn, Tornimäe 3. The AGM was attended by 60 shareholders and their authorised representatives who represented a total of 11,324,722 votes accounting for 61.22% of the total votes. The decisions of the General Meeting were as follows:1. Approval to AS Harju Elekter Group annual report of 2023 Approve the 2023 Annual Report prepared by the Management Board and approved by the Sup...
AS-i Harju Elekter Group aktsionäride üldkoosoleku otsused 26. aprillil 2024 kell 14 toimus Swissotel Tallinn AS-i Harju Elekter Group (registrikood 10029524, aadress Paldiski mnt 31/2, Keila) aktsionäride korraline üldkoosolek. Üldkoosolekust võttis osa 60 aktsionäri ja nende volitatud esindajat, kes olid esindatud kokku 11 324 722 häälega, mis moodustab häälte üldarvust 61,22%. AS-i Harju Elekter Group aktsionäride üldkoosolek otsustas:1. AS-i Harju Elekter Group 2023. a majandusaasta aruande kinnitamine Kinnitada AS-i Harju Elekter Group juhatuse poolt koostatud ja nõukogu pool...
Savencia : Communiqué de mise à disposition du rapport financier annuel au 31 décembre 2023 Communiqué de mise à disposition du rapport financier annuel au 31 décembre 2023 La société annonce avoir mis à disposition du public et déposé auprès de l’Autorité des Marchés Financiers son rapport financier annuel au 31 décembre 2023. Le rapport financier annuel peut être consulté sur le site internet de la société à l’adresse -fromagedairy.com, dans la rubrique « information réglementée ». Viroflay, le 26 avril 2024 Pièce jointe
Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP) April 26, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for theTreatment of Familial Adenomatous Polyposis (FAP) Worldwide rights come with $17 million in non-dilutive grant funding for Pivotal Phase 3 trial in FAP An estimated 100,000 in U.S. and Europe are afflicted with FAP, precancerous polyps that typically lead to surgical removal of the colon and/or rectum In FAP, ...
Crédit Agricole Normandie Seine : communiqué financier trimestriel au 31 mars 2024 RESULTATS AU 31 MARS 2024 Bois-Guillaume, le 26 avril 2024 Un premier trimestre de l’année 2024 impacté par un contexte économique en berne Impactée par le contexte économique européen de faible croissance, l’activité du 1er trimestre 2024 a été marquée par une faible dynamique d’investissement des entreprises et des ménages du territoire. Ce trimestre a été pour la Caisse Régionale Normandie-Seine un temps fort de rencontre de nos clients, illustrant l’intensité relationnelle que nous souhaito...
Correction Sono Group N.V. Announces Ticker Symbol Update and New Leadership Team as It Prepares for Market Advancement MUNICH, Germany, April 26, 2024 (GLOBE NEWSWIRE) -- Sono Group N.V. (the “Company”) (OTC: SEVCF), a solar technology company, today announced a correction to its press release issued on April 25, 2024, which provided an update on the trading symbol for the Company's ordinary shares and introduced the new leadership team. The original press release incorrectly stated that the Company's ordinary shares would be quoted on the over-the-counter market under the U.S. ticker ...
Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma $15 million CIRM Grant Supports the Ongoing Phase 1 TRAVERSE Trial Evaluating ALLO-316 in Patients with Advanced or Metastatic Renal Cell Carcinoma (RCC)ALLO-316 Illustrates Proof-of-Concept in RCC and the Potential of Dagger® Technology to Optimize CAR T Cell Expansion and Persistence SOUTH SAN FRANCISCO, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology comp...
Rigetti Computing Launches the Novera™ QPU Partner Program The Novera QPU Partner Program aims to enable high-performing, on-premises quantum computing by creating an ecosystem of quantum computing hardware, software, and service providers who build and offer integral components of a functional quantum computing system. Novera QPU customers can work with Novera QPU partners to build a quantum computer powered by the Novera QPU that satisfies their system requirements and quantum computing research objectives. BERKELEY, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. ...
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda — If approved in the European Union, fruquintinib will be the first novel targeted therapy for metastatic colorectal cancer regardless of biomarker status in over a decade — — Positive opinion based on results from FRESCO-2 Phase III clinical trial — HONG KONG, SHANGHAI, China and FLORHAM PARK, N.J., April 26, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“”) (Nasdaq/AIM:HCM; HKEX:13) today announces that its partner (TSE:4502/NYSE:TAK) received noti...
ALPHAMIN DECLARES FINAL FY2023 DIVIDEND GRAND BAIE, MAURITIUS, April 26, 2024 (GLOBE NEWSWIRE) -- Alphamin Resources Corp. (AFM:TSXV, APH:JSE AltX)( “Alphamin” or the “Company”) announced today that its Board of Directors has declared a Final FY2023 cash dividend of CAD$0.03 per share on the common shares (approximately US$27.9 million in the aggregate) (the “Dividend”). The Dividend will be payable on 24 May, 2024 to shareholders of record as of the close of business on 17 May, 2024. _________________________________________________________________________________________ FOR MORE INFO...
CEMATRIX Announces $7.6 Million in New Contracts and a Reduction in Scope of a Previously Awarded Tunnel Project CALGARY, Alberta, April 26, 2024 (GLOBE NEWSWIRE) -- CEMATRIX Corporation (TSXV: CVX) (OTCQB: CTXXF) ("CEMATRIX" or the "Company") a North American leading manufacturer and supplier of technologically advanced cellular concrete products today announced that it has executed $7.6 million in new contracts. A portion of the $7.6 million in new contracts is derived from two projects, with price tags greater than $1 million Canadian, and were previously included in Contracts in Proc...
Exagen Inc. Announces Changes to the Board of Directors CARLSBAD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced changes to the Board of Directors. Exagen is pleased to announce Scott Kahn, Ph.D. is joining the Board as a Class I Director. Dr. Kahn has a distinguished career in life sciences spending over 30 years in global leadership positions. Prior to starting his career in the life science industry, he was an assistant professor of organic chemistry at the University of Illinois. He spent ove...
Mount Logan Capital Inc. Schedules Release of First Quarter 2024 Results TORONTO, April 26, 2024 (GLOBE NEWSWIRE) -- Mount Logan Capital Inc. (NEO: MLC) (“Mount Logan” or the “Company”) will release its financial results for the first quarter ended March 31, 2024 after market close on Thursday, May 9, 2024. The Company will host a conference call on Friday, May 10, 2024, at 11:00 a.m. Eastern Time to discuss these results. Shareholders, prospective shareholders, and analysts are welcome to listen to the conference call. To join the call, please use the dial-in information below. A recordi...
Bannix Acquisition Corp. Receives Nasdaq Notification of Non-Compliance With Listing Rules WEST HOLLYWOOD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Bannix Acquisition Corp. (NASDAQ: BNIX) (“Bannix” or the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced that on April 25, 2024, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“NASDAQ”) advising the Company that the Company did not...
LiveOne (NASDAQ: LVO) Expands Pay-Per-View Lineup with “KnuckleMania IV” Partnering with Bare Knuckle (BKFC) for “Perry vs. Alves" PPV Event on Saturday, April 27, 2024 PPV Tickets Available for $29.99 at LiveOne.com LiveOne Continues to Dominate Live Streaming with Impressive Milestones: 252,268 PPV Tickets Sold200+ Million Viewers Reached5 Billion Engagements with Fans Across 220 Countries Highlighted PPV Events: Wiz Khalifa, MonsterX, Pitbull Social GlovesFloyd Mayweather vs. Logan PaulFloyd Mayweather vs. DejiIce Wars III: Outlaw EnforcersShowstar UK vs USA: Deji vs. WassabiGlobal...
VCI Global Announces Earnings Call and Business Update on April 30th, 2024 KUALA LUMPUR, Malaysia, April 26, 2024 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, “VCIG”, or the “Company”), is pleased to announce that it has scheduled an investor conference call at 8:00 a.m. Eastern Time on Tuesday, April 30th, 2024. “We are very excited and look forward to sharing with our investors the growth that our company has seen over this last year,” stated Dato’ Victor Hoo, Group Executive Chairman and Chief Executive Officer of VCI Global. Please call the conference telepho...
AUDACIA : RESULTATS ANNUELS 2023 : HAUSSE DES AUM ET APPRECIATION DE L’ANR PAR ACTION RESULTATS ANNUELS 2023 : HAUSSE DES AUM ET APPRECIATION DE L’ANR PAR ACTION Hausse de 11% du CA consolidé et progression du Résultat d’exploitation de 42%Réalisation de 62 opérations dont 23 investissements dans des sociétés nouvellesCroissance de 26% des AUM1 à 510 M€, intégralement liée aux Nouveaux FondsActif Net Réévalué : 21,8 M€, soit 4,58€ par action2 « Nous nous réjouissons des performances 2023 d’Audacia, qui confirment l’accélération de la transformation du Groupe. Nos...
Qifu Technology Releases 2023 ESG Report SHANGHAI, China, April 26, 2024 (GLOBE NEWSWIRE) -- Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading Credit-Tech platform in China, today published its annual ESG report for 2023. The report demonstrates Qifu Technology’s ESG-related guidelines, strategies and targets in 2023, highlighting the Company’s efforts to environmental sustainability and social responsibility, the progress to improve corporate governance, and its ESG performance. In the future, Qifu Technology will stay committed to enabling...
KE Holdings Inc. Files Its Annual Report on Form 20-F BEIJING, April 26, 2024 (GLOBE NEWSWIRE) -- KE Holdings Inc. (“Beike” or the “Company”) (NYSE: BEKE; HKEX: 2423), a leading integrated online and offline platform for housing transactions and services, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the Securities and Exchange Commission on April 26, 2024. The annual report can be accessed on the Company’s investor relations website at . The Company will provide a hard copy of its annual report containing the audited consol...
Wayne Savings Bancshares, Inc. Announces Earnings for First Quarter of 2024 First Quarter 2024 Highlights Customer deposit balances increased by 10.3% annualizedNonperforming loan balances declined to 0.05% of net loansReceived regulatory approval for merger with Main Street Financial Services, Corp. WOOSTER, Ohio, April 26, 2024 (GLOBE NEWSWIRE) -- Wayne Savings Bancshares, Inc. (OTCQX: WAYN), (the “Company”), the holding company parent of Wayne Savings Community Bank, reported net income (unaudited) of $1.5 million, or $0.70 per common share, for the three...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.